Project Number GC-201810-2017455 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2019 View Full Project Details for Human PET Imaging Evaluations of the Astroglial L-Glutamate EAAT2 Tracer for Alzheimer’s Disease and Related Dementias Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers c. PET Other Imaging Researcher and Organization Principal Investigator Gerdes, John Principal Investigator First Name John Principal Investigator Last Name Gerdes Awardee Organization RIO Pharmaceuticals, Inc. Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement Neuroimaging and CSF Biomarker Development RFP FY Overall Cost $308,869 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
